Overview

Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This research study is examining a preventive skin care regimen for children diagnosed with a brain tumor and receiving anti-cancer therapy with a MEK, Pan-RAF, or BRAF inhibitor.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute